IL149524A0 - HMG-CoA REDUCTASE INHIBITOR EXTENDED RELEASE FORMULATIONS - Google Patents
HMG-CoA REDUCTASE INHIBITOR EXTENDED RELEASE FORMULATIONSInfo
- Publication number
- IL149524A0 IL149524A0 IL14952400A IL14952400A IL149524A0 IL 149524 A0 IL149524 A0 IL 149524A0 IL 14952400 A IL14952400 A IL 14952400A IL 14952400 A IL14952400 A IL 14952400A IL 149524 A0 IL149524 A0 IL 149524A0
- Authority
- IL
- Israel
- Prior art keywords
- hmg
- coa reductase
- extended release
- release formulations
- reductase inhibitor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US43557699A | 1999-11-08 | 1999-11-08 | |
PCT/US2000/030415 WO2001034123A1 (en) | 1999-11-08 | 2000-11-03 | Hmg-coa reductase inhibitor extended release formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
IL149524A0 true IL149524A0 (en) | 2002-11-10 |
Family
ID=23728948
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14952400A IL149524A0 (en) | 1999-11-08 | 2000-11-03 | HMG-CoA REDUCTASE INHIBITOR EXTENDED RELEASE FORMULATIONS |
Country Status (8)
Country | Link |
---|---|
AU (1) | AU768950B2 (en) |
CA (1) | CA2390301A1 (en) |
DE (1) | DE10085183T1 (en) |
GB (1) | GB2371748B (en) |
HK (1) | HK1050134A1 (en) |
IL (1) | IL149524A0 (en) |
NZ (1) | NZ518770A (en) |
WO (1) | WO2001034123A1 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003080026A1 (en) * | 2002-03-22 | 2003-10-02 | Ranbaxy Laboratories Limited | Controlled release drug delivery system of pravastatin |
US20040132802A1 (en) * | 2002-09-03 | 2004-07-08 | Jackie Butler | Pharmaceutical formulations and methods for modified release of statin drugs |
CA2588215A1 (en) * | 2004-11-22 | 2006-05-26 | Dexcel Pharma Technologies Ltd. | Controlled absorption of statins in the intestine |
EP2079448A2 (en) * | 2006-10-10 | 2009-07-22 | Dexcel Pharma Technologies Ltd. | Improved release of statins in the intestine |
AU2014239164B2 (en) | 2013-03-15 | 2018-12-06 | Cedars-Sinai Medical Center | Methods of diagnosis, selection, and treatment of diseases and conditions caused by or associated with methanogens |
US9289418B2 (en) | 2013-03-15 | 2016-03-22 | Cedars-Sinai Medical Center | Methods of diagnosis, selection, and treatment of diseases and conditions caused by or associated with methanogens |
BR112017002761A2 (en) | 2014-08-13 | 2017-12-19 | Cedars Sinai Medical Center | anti-methanogenic compositions and uses thereof |
EP3277274B1 (en) | 2015-04-01 | 2024-06-12 | Cedars-Sinai Medical Center | Anti-methanogenic lovastatin analogs or derivatives and uses thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5366738A (en) * | 1982-07-29 | 1994-11-22 | Merck & Co., Inc. | Controlled release drug dispersion delivery device |
US4915954A (en) * | 1987-09-03 | 1990-04-10 | Alza Corporation | Dosage form for delivering a drug at two different rates |
US5244916A (en) * | 1992-01-31 | 1993-09-14 | The Scripps Research Institute | Inhibition of respiratory burst using posttranslational modification inhibitors |
US5518730A (en) * | 1992-06-03 | 1996-05-21 | Fuisz Technologies Ltd. | Biodegradable controlled release flash flow melt-spun delivery system |
IN176897B (en) * | 1993-10-29 | 1996-09-28 | Cadila Lab Ltd | |
US5582838A (en) * | 1994-12-22 | 1996-12-10 | Merck & Co., Inc. | Controlled release drug suspension delivery device |
-
2000
- 2000-11-03 AU AU13607/01A patent/AU768950B2/en not_active Ceased
- 2000-11-03 WO PCT/US2000/030415 patent/WO2001034123A1/en active IP Right Grant
- 2000-11-03 CA CA002390301A patent/CA2390301A1/en not_active Abandoned
- 2000-11-03 DE DE10085183T patent/DE10085183T1/en not_active Ceased
- 2000-11-03 NZ NZ518770A patent/NZ518770A/en not_active IP Right Cessation
- 2000-11-03 GB GB0210619A patent/GB2371748B/en not_active Expired - Lifetime
- 2000-11-03 IL IL14952400A patent/IL149524A0/en unknown
-
2003
- 2003-02-07 HK HK03100941A patent/HK1050134A1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
GB0210619D0 (en) | 2002-06-19 |
AU1360701A (en) | 2001-06-06 |
WO2001034123A1 (en) | 2001-05-17 |
NZ518770A (en) | 2004-02-27 |
GB2371748B (en) | 2004-12-01 |
DE10085183T1 (en) | 2002-10-24 |
GB2371748A (en) | 2002-08-07 |
HK1050134A1 (en) | 2003-06-13 |
AU768950B2 (en) | 2004-01-08 |
CA2390301A1 (en) | 2001-05-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0104258A3 (en) | Stable pharmaceutical formulation comprising a hmg-coa reductase inhibitor | |
IL147870A0 (en) | Pharmaceutical compositions comprising a hmg reductase inhibitor | |
GB9900416D0 (en) | Inhibitors | |
AU3368400A (en) | Aerosol compositions of hmg-coa reductase inhibitors for inhibiting inflammationassociated with pulmonary disease | |
AU1530001A (en) | Inhibitor compositions | |
EP1286702A4 (en) | HMG CoA REDUCTASE INHIBITORS FOR PROMOTING ANGIOGENESIS | |
AU2002310798A1 (en) | Pharmaceutical compositions comprising a hmg-coa reductase inhibitor | |
AU2003250172A1 (en) | Compositions comprising hmg-coa reductase inhibitor | |
HK1047276A1 (en) | Tetrahydrothiopy ranphthalazinone derivatives as pde4 inhibitors | |
IL132786A0 (en) | Hmg-coa reductase inhibitor preparation process | |
IL149524A0 (en) | HMG-CoA REDUCTASE INHIBITOR EXTENDED RELEASE FORMULATIONS | |
AU3235100A (en) | Prothease inhibitors | |
AU2001280461A1 (en) | Substituted pyrrole compounds and their use as spla2 inhibitors | |
GB2389113B (en) | B-secretase inhibitor | |
AU5762899A (en) | Caspase inhibitor | |
AU2001269121A1 (en) | Substituted amidoalkyl-uracils as parp inhibitors | |
HUP0105145A3 (en) | Process for producing hmg-coa reductase inhibitor | |
HUP0201597A2 (en) | Antilipemic combunations comprising hmg-coa reductase inhibitors and carnitines | |
GB9911546D0 (en) | Release of poorly soluble agents | |
HUP0301728A3 (en) | Hmg-coa reductase inhibiting pharmaceutical compositions and their use | |
AU2001228647A1 (en) | Dihydrofolate reductase inhibitors | |
HK1077230A1 (en) | Medicinal composition hmg-coa reductase inhibitor | |
AU1548801A (en) | Melanogenesis inhibitor | |
AU2002400A (en) | Telomerase inhibitors | |
AUPQ318099A0 (en) | Impact inhibitor |